
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Hevea Capital is a venture capital firm founded by Brian Condenanza in the United States. The firm specializes in early-stage investments, focusing on companies that are building the foundational infrastructure of tomorrow's economy. Hevea Capital operates with a thesis-driven approach, emphasizing the strategic importance of regulatory frameworks in high-growth markets.
Currently, Hevea Capital manages a portfolio of 9 companies and targets investments across various stages, including pre-seed, seed, seed-plus, and Series A. The firm has a global investment strategy, with a particular focus on markets in Latin America, Europe, Southeast Asia, and the Middle East & North Africa. Hevea Capital's commitment to identifying and supporting innovative founders positions it as a significant player in the venture capital landscape.
Hevea Capital invests in frontier technologies, which include sectors such as artificial intelligence, fintech, healthcare, and regulatory technology. The firm targets scalable systems that align innovation with long-term institutional relevance. Their investment strategy is particularly focused on backing founders who view regulation as an opportunity rather than a constraint, which is crucial in high-growth markets.
The firm maintains a strong emphasis on global markets, especially in Latin America and Europe, while also selectively exploring opportunities in Southeast Asia and the Middle East & North Africa. Hevea Capital's approach is to identify companies that are not only innovative but also capable of navigating complex regulatory environments, thereby positioning themselves for sustainable growth.
Hevea Capital's portfolio includes a diverse range of companies that exemplify its focus on frontier technologies:
This portfolio reflects Hevea Capital's commitment to investing in companies that are at the forefront of technological advancement and regulatory innovation.
Brian Condenanza: Founder of Hevea Capital, Brian has extensive experience in venture capital and a strong focus on regulatory technology and frontier innovations. His background includes working with various startups and understanding the intricacies of high-growth markets.
Founders interested in pitching to Hevea Capital should reach out via email at hello@hevea.capital. It is recommended to include a concise pitch deck that outlines the business model, market opportunity, and how the startup aligns with Hevea's investment thesis. Response times may vary, but founders should expect to hear back within a few weeks.
What stages does Hevea Capital invest in?
Hevea Capital invests in pre-seed, seed, seed-plus, and Series A stages, focusing on early-stage companies.
What sectors does Hevea Capital focus on?
The firm focuses on sectors such as artificial intelligence, fintech, healthcare, and regulatory technology.
How does Hevea Capital view regulation in its investments?
Hevea Capital views regulation as an opportunity rather than a constraint, seeking founders who align with this perspective.
What is the geographic focus of Hevea Capital?
The firm primarily targets markets in Latin America and Europe, with selective investments in Southeast Asia and the Middle East & North Africa.
How can founders pitch to Hevea Capital?
Founders can pitch to Hevea Capital by reaching out via email at hello@hevea.capital. It is advisable to include a clear overview of the business model and how it aligns with the firm's investment thesis.
What makes Hevea Capital different from other VC firms?
Hevea Capital differentiates itself by emphasizing the importance of regulatory frameworks as strategic advantages in high-growth markets, focusing on scalable systems in frontier technologies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.